Watch Ticker

Cue Biopharma, Inc.

Go to Cue Biopharma, Inc. Website

$1.55

(%)

Live

Previous Close

$1.55

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$75.4 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Zacks Equity Research - Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates

Insmed (INSM) delivered earnings and revenue surprises of 13.11% and 4.28%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Related tickers: INSM, CUE.

Read Full Article

Cue Biopharma, Inc. - Cue Biopharma to Present at the 20th Annual PEGS Boston Summit

BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, announced today that it will deliver two poster presentations at the 20th PEGS Boston Summit, the Essential Protein and Antibody Engineering Summit, being held May 13-17, 2024 in Boston, MA and virtually.

Related tickers: CUE.

Read Full Article

Trending Tickers

CYTO

XNAS

$1.44

(%)

LASE

XNAS

$2.24

(%)

MGAM

XNAS

$0.02

(%)

SXTC

XNAS

$1.11

(%)

MLGO

XNAS

$0.00

(%)